Antitumor Effect of a Novel Proapoptotic Peptide that Impairs the Phosphorylation by the Protein Kinase 2 (Casein Kinase 2)
Open Access
- 1 October 2004
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 64 (19), 7127-7129
- https://doi.org/10.1158/0008-5472.can-04-2086
Abstract
Protein Kinase (casein kinase 2, CK2) is a serine-threonine kinase that is frequently dysregulated in many human tumors. Therefore we hypothesized that peptides capable of binding to the CK2 acidic domain may exhibit potential anticancer properties. By screening a random cyclic peptide phage display library, we have identified a novel peptide, P15, that abrogated CK2 phosphorylation by blocking the substrate in vitro. To verify its potential antineoplastic effect, P15 was fused to the cell-penetrating peptide derived from the HIV-Tat protein. Interestingly, P15-Tat induced apoptosis as evidenced by rapid caspase activation and cellular cytotoxicity in a variety of tumor cell lines. Furthermore, direct injection of P15-Tat into C57BL6 mice bearing day 7-established solid tumors, resulted in substantial regression of the tumor mass. Our findings describe a new proapoptotic cyclic peptide that blocks the CK2 phosphorylation and exhibits antitumor effect in vivo, indicating that the P15 peptide may potentially be used clinically to treat solid tumors or as an adjuvant for cancer therapy.Keywords
This publication has 9 references indexed in Scilit:
- Functional interaction of protein kinase CK2 and c-Myc in lymphomagenesisOncogene, 2002
- Phosphorylation by Protein Kinase CK2Molecular Cell, 2002
- Protein kinase CK2 inhibitor 4,5,6,7-tetrabromobenzotriazole (TBB) induces apoptosis and caspase-dependent degradation of haematopoietic lineage cell-specific protein 1 (HS1) in Jurkat cellsBiochemical Journal, 2002
- Joining the cell survival squad: an emerging role for protein kinase CK2Trends in Cell Biology, 2002
- Apoptosis-mediated enhancement of DNA-raised immune responses by mutant caspasesNature Biotechnology, 2001
- Internalization of HIV-1 Tat Requires Cell Surface Heparan Sulfate ProteoglycansJournal of Biological Chemistry, 2001
- Signalling properties of an HIV-encoded angiogenic peptide mimicking vascular endothelial growth factor activityBiochemical Journal, 2001
- In vivo protein transduction: intracellular delivery of biologically active proteins, compounds and DNATrends in Pharmacological Sciences, 2000
- Selection of antibody ligands from a large library of oligopeptides expressed on a multivalent exposition vectorJournal of Molecular Biology, 1991